Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-12

FDA Approved: ZONISAMIDE — Supplemental Application (Exelan Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for zonisamide (Exelan Pharmaceuticals) under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonisamide (zonisamide)

Snippet

SUPPL AP for ZONISAMIDE (ZONISAMIDE)